You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃森生物(300142.SZ):目前雙價HPV疫苗僅公司在內的兩家企業實現國產
格隆匯 05-12 07:43

格隆匯5月12日丨有投資者在投資者互動平台向沃森生物(300142.SZ)提問,“貴司稱貴司2價HPV主要以惠民工程為主,截至目前,浙江麗水、海南HPV招標均以投標企業不足廢標,目前國內僅貴司與萬泰有2價HPV,萬泰2價HPV在市場化銷售下已滿產,如果每次招標萬泰均不投標,請問貴司有何應對戰略?”

沃森生物回覆稱,目前雙價HPV疫苗僅公司在內的兩家企業實現國產,根據現行法規,在公開招投標應標不足三家的情況下,可採取競爭性談判或單一來源採購方式確認供應商。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account